The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
In the latest session, Black Diamond Therapeutics Inc (NASDAQ: BDTX) closed at $3.82 up 1.06% from its previous closing price of $3.78. In other words, the price has increased by $1.06 from its previous closing price. On the day, 0.64 million shares were traded. BDTX stock price reached its highest trading level at $3.9 during the session, while it also had its lowest trading level at $3.8.
Ratios:
For a deeper understanding of Black Diamond Therapeutics Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.61 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.19. For the most recent quarter (mrq), Quick Ratio is recorded 8.94 and its Current Ratio is at 8.94. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.13.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 19 ’25 when BIOTECH GROWTH N V sold 5,784,292 shares for $2.07 per share. The transaction valued at 11,997,749 led to the insider holds 2,733,547 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BDTX now has a Market Capitalization of 217644160 and an Enterprise Value of 101811168. As of this moment, Black’s Price-to-Earnings (P/E) ratio for their current fiscal year is 10.53. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.94. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.11 while its Price-to-Book (P/B) ratio in mrq is 1.72. Its current Enterprise Value per Revenue stands at 1.454 whereas that against EBITDA is 6.722.
Stock Price History:
The Beta on a monthly basis for BDTX is 3.34, which has changed by 0.47490346 over the last 52 weeks, in comparison to a change of 0.1326145 over the same period for the S&P500. Over the past 52 weeks, BDTX has reached a high of $4.94, while it has fallen to a 52-week low of $1.20. The 50-Day Moving Average of the stock is -1.59%, while the 200-Day Moving Average is calculated to be 43.05%.
Shares Statistics:
For the past three months, BDTX has traded an average of 993.37K shares per day and 1113520 over the past ten days. A total of 56.94M shares are outstanding, with a floating share count of 44.75M. Insiders hold about 21.46% of the company’s shares, while institutions hold 58.80% stake in the company. Shares short for BDTX as of 1763078400 were 6356283 with a Short Ratio of 6.40, compared to 1760486400 on 6198261. Therefore, it implies a Short% of Shares Outstanding of 6356283 and a Short% of Float of 16.009999999999998.
Earnings Estimates
Current recommendations for the stock of the company come from 7.0 analysts. The consensus estimate for the next quarter is $0.06, with high estimates of $1.03 and low estimates of -$0.22.
Analysts are recommending an EPS of between $0.56 and $0.34 for the fiscal current year, implying an average EPS of $0.44. EPS for the following year is -$0.61, with 7.0 analysts recommending between -$0.19 and -$0.83.